| DIRECT COMPETITOR COMPARISON | |
No Direct Competitor Comparision
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.79 | -0.75% | 57.48B | 12.39 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 53.18 | -0.37% | 15.38B | 17.80 | | Genzyme Corp. | GENZ | 48.49 | 0.52% | 12.87B | 27.65 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 44.87 | 3.72% | 40.38B | 17.35 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 51.97 | 0.78% | 9.27B | 1060.61 | | Teva Pharmaceutical Industries Limited | TEVA | 57.2815 | 0.39% | 50.47B | 52.41 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 39.86 | -0.08% | 4.23B | 20.55 | | King Pharmaceuticals Inc. | KG | 12.69 | 1.20% | 3.15B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.40 | -0.65% | 5.62B | 112.88 | | Pfizer Inc. | PFE | 18.66 | 0.00% | 150.58B | 15.50 | | Johnson & Johnson | JNJ | 64.10 | 0.27% | 176.86B | 14.00 | | GlaxoSmithKline plc | GSK | 41.4935 | -0.80% | 105.19B | 13.47 | | Sanofi-Aventis | SNY | 40.04 | -0.65% | 104.55B | N/A | | Novartis AG | NVS | 52.70 | 0.27% | 119.69B | 15.78 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 43.67 | 0.99% | N/A | N/A | | AstraZeneca plc | AZN | 46.03 | -0.90% | 66.74B | 9.24 | | Abbott Laboratories | ABT | 54.079 | 0.11% | 83.65B | 14.65 | | Bristol-Myers Squibb Co. | BMY | 25.19 | -0.16% | 49.90B | 13.03 |
|
| NEWS ON DIRECT COMPETITORS | |
No News on Direct Competitors |
|
|
0.16% Nasdaq 
Competitors
